Dietary Sugar and Artificial Sweetener Intake and Chronic Kidney Disease: A Review

Advances in Chronic Kidney Disease

Volumn 20, Issue 2, 2013, Pages 157-164

  Karalius, Vytas P ^a   Shoham, David A ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Carbonated beverages; Dietary carbohydrates; Epidemiology; Fructose; Kidney insufficiency

Indexed keywords

ALCOHOL; FRUCTOSE; GLUCOSE; SUCROSE; SWEETENING AGENT; URIC ACID;

ALCOHOL CONSUMPTION; BEVERAGE; CALORIC INTAKE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIETARY INTAKE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; KIDNEY HYPERTROPHY; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SODIUM INTAKE; SUGAR INTAKE; URIC ACID BLOOD LEVEL; WEIGHT GAIN;

CARBONATED BEVERAGES; DIABETES MELLITUS; DIETARY SUCROSE; FRUCTOSE; HUMANS; HYPERTENSION; HYPERURICEMIA; OBESITY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SWEETENING AGENTS;

EID: 84874237684     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2012.12.005     Document Type: Review

References (66)

1. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. J Am Med Assoc 2007, 298:2038-2047.
2. Muntner P., Coresh J., Powe N.R., Klag M.J. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol 2003, 14:1568-1577.
3. Chalmers L., Kaskel F.J., Bamgbola O. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Adv Chronic Kidney Dis 2006, 13:352-364.
4. Lastra G., Manrique C., Sowers J.R. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv Chronic Kidney Dis 2006, 13:365-373.
5. Kramer H., Luke A. Obesity and kidney disease: a big dilemma. Curr Opin Nephrol Hypertens 2007, 16:237-241.
6. Bray G.A., Nielsen S.J., Popkin B.M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004, 79:537-543.
7. Johnson R.J., Segal M.S., Sautin Y., et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007, 86:899-906.
8. Gross L.S., Li L., Ford E.S., Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004, 79:774-779.
9. Putnam J.J., Allshouse J.E. Food Consumption, Prices, and Expenditures, 1970-97 1999, U.S. Department of Agriculture Economic Research Service, Washington, DC.
10. Duffey K.J., Popkin B.M. High-fructose corn syrup: is this what's for dinner?. Am J Clin Nutr 2008, 88:1722S-1732S.
11. Duffey K.J., Popkin B.M. Shifts in patterns and consumption of beverages between 1965 and 2002. Obesity (Silver Spring) 2007, 15:2739-2747.
12. Neilson E.G. The fructose nation. J Am Soc Nephrol 2007, 18:2619-2621.
13. Ferder L., Ferder M.D., Inserra F. The role of high-fructose corn syrup in metabolic syndrome and hypertension. Curr Hypertens Rep 2010, 12:105-112.
14. Malik V.S., Popkin B.M., Bray G.A., Despres J.P., Willett W.C., Hu F.B. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010, 33:2477-2483.
15. Rho Y.H., Zhu Y., Choi H.K. The epidemiology of uric acid and fructose. Semin Nephrol 2011, 31:410-419.
16. Yamada T., Fukatsu M., Suzuki S., Wada T., Joh T. Elevated serum uric acid predicts chronic kidney disease. Am J Med Sci 2011, 342:461-466.
17. Sonoda H., Takase H., Dohi Y., Kimura G. Uric acid levels predict future development of chronic kidney disease. Am J Nephrol 2011, 33:352-357.
18. Satirapoj B., Supasyndh O., Nata N., et al. High levels of uric acid correlate with decline of glomerular filtration rate in chronic kidney disease. J Med Assoc Thai 2011, 93(suppl 6):S65-S70.
19. Sturm G., Kollerits B., Neyer U., Ritz E., Kronenberg F. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol 2008, 43:347-352.
20. Bellomo G., Venanzi S., Verdura C., Saronio P., Esposito A., Timio M. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis 2010, 56:264-272.
21. Johnson E.S., Smith D.H., Thorp M.L., Yang X., Juhaeri J. Predicting the risk of end-stage renal disease in the population-based setting: a retrospective case-control study. BMC Nephrol 2011, 12:17.
22. Yu K.H., Kuo C.F., Luo S.F., et al. Risk of end-stage renal disease associated with gout: a nationwide population study. Arthritis Res Ther 2012, 14:R83.
23. Kramer H.M., Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002, 40:37-42.
24. Short R.A., Tuttle K.R. Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspective. Semin Nephrol 2005, 25:25-31.
25. Gao X., Qi L., Qiao N., et al. Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension 2007, 50:306-312.
26. Choi J.W., Ford E.S., Gao X., Choi H.K. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008, 59:109-116.
27. Choi H.K., Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008, 336:309-312.
28. Choi H.K., Willett W., Curhan G. Fructose-rich beverages and risk of gout in women. J Am Med Assoc 2010, 304:2270-2278.
29. Yang T., Chu C.H., Bai C.H., et al. Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study. Metabolism 2012, 61:1747-1755.
30. Masuo K., Kawaguchi H., Mikami H., Ogihara T., Tuck M.L. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003, 42:474-480.
31. Ford E.S., Li C., Cook S., Choi H.K. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007, 115:2526-2532.
32. Choi H.K., Ford E.S., Li C., Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007, 57:109-115.
33. Chaloupka F.J., Powell L.M., Chriqui J.F. Sugar-sweetened beverages and obesity prevention: policy recommendations. J Policy Anal Manage 2011, 30:662-664.
34. Hu F.B., Malik V.S. Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiol Behav 2010, 100:47-54.
35. Malik V.S., Popkin B.M., Bray G.A., Despres J.P., Hu F.B. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010, 121:1356-1364.
36. Raben A., Vasilaras T.H., Moller A.C., Astrup A. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr 2002, 76:721-729.
37. Stanhope K.L., Schwarz J.M., Keim N.L., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009, 119:1322-1334.
38. Kramer H., Shoham D., McClure L.A., et al. Association of waist circumference and body mass index with all-cause mortality in CKD: the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis 2011, 58:177-185.
39. Balkau B., Deanfield J.E., Despres J.P., et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007, 116:1942-1951.
40. Thomas G., Sehgal A.R., Kashyap S.R., Srinivas T.R., Kirwan J.P., Navaneethan S.D. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2011, 6:2364-2373.
41. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
42. Kahn R., Buse J., Ferrannini E., Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289-2304.
43. Raben A., Moller B.K., Flint A., et al. Increased postprandial glycaemia, insulinemia, and lipidemia after 10 weeks' sucrose-rich diet compared to an artificially sweetened diet: a randomised controlled trial. Food Nutr Res 2011, 55:721-729.
44. Faeh D., Minehira K., Schwarz J.M., Periasamy R., Park S., Tappy L. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 2005, 54:1907-1913.
45. Chen L., Caballero B., Mitchell D.C., et al. Reducing consumption of sugar-sweetened beverages is associated with reduced blood pressure: a prospective study among United States adults. Circulation 2010, 121:2398-2406.
46. Jalal D.I., Smits G., Johnson R.J., Chonchol M. Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 2010, 21:1543-1549.
47. Nguyen S., Choi H.K., Lustig R.H., Hsu C.Y. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr 2009, 154:807-813.
48. Nettleton J.A., Lutsey P.L., Wang Y., Lima J.A., Michos E.D., Jacobs D.R. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2009, 32:688-694.
49. Duffey K.J., Steffen L.M., Van Horn L., Jacobs D.R., Popkin B.M. Dietary patterns matter: diet beverages and cardiometabolic risks in the longitudinal Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Clin Nutr 2012, 95:909-915.
50. Gersch M.S., Mu W., Cirillo P., et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Ren Physiol 2007, 293:F1256-F1261.
51. Sanchez-Lozada L.G., Tapia E., Jimenez A., et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Ren Physiol 2007, 292:F423-F429.
52. Bomback A.S., Derebail V.K., Shoham D.A., et al. Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int 2010, 77:609-616.
53. Saldana T.M., Basso O., Darden R., Sandler D.P. Carbonated beverages and chronic kidney disease. Epidemiology 2007, 18:501-506.
54. Shoham D.A., Durazo-Arvizu R., Kramer H., et al. Sugary soda consumption and albuminuria: results from the National Health and Nutrition Examination Survey, 1999-2004. PLoS One 2008, 3:e3431.
55. Bomback A.S., Katz R., He K., Shoham D.A., Burke G.L., Klemmer P.J. Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2009, 90:1172-1178.
56. Lin J., Curhan G.C. Associations of sugar and artificially sweetened soda with albuminuria and kidney function decline in women. Clin J Am Soc Nephrol 2010, 6:160-166.
57. Freedman L.S., Schatzkin A., Midthune D., Kipnis V. Dealing with dietary measurement error in nutritional cohort studies. J Natl Cancer Inst 2011, 103:1086-1092.
58. He F.J., Marrero N.M., MacGregor G.A. Salt intake is related to soft drink consumption in children and adolescents: a link to obesity?. Hypertension 2008, 51:629-634.
59. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 1965, 58:295-300.
60. Brymora A., Flisinski M., Johnson R.J., Goszka G., Stefanska A., Manitius J. Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease. Nephrol Dial Transplant 2011, 27:608-612.
61. Sugar Sweetened Beverages: Background 2012, U.S. Department of Agriculture, Washington, DC.
62. Huang T.T., Glass T.A. Transforming research strategies for understanding and preventing obesity. J Am Med Assoc 2008, 300:1811-1813.
63. Torralba A.S. Susceptibility of non-linear systems as an approach to metabolic responses. Bioinformatics 2003, 19:2428-2435.
64. Shoham D.A., Tong L., Lamberson P.J., et al. An actor-based model of social network influence on adolescent body size, screen time, and playing sports. PLoS One 2012, 7:e39795.
65. Christakis N.A., Fowler J.H. The spread of obesity in a large social network over 32 years. N Engl J Med 2007, 357:370-379.
66. Gortmaker S.L., Swinburn B.A., Levy D., et al. Changing the future of obesity: science, policy, and action. Lancet 2011, 378:838-847.